Key facts
- Notable investors include Green Pine Capital Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Synthetic Era
- ·The full record, as it builds
Funding rounds
No funding rounds for Synthetic Era are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synthetic Era
Developer of industrial enzyme and related products intended for advanced material innovation purposes. The company focuses on the R&D of industrial enzyme, biochemical product technology, fermentation process optimization technology and provides multifunctional enzyme and enzyme-metal composite catalyst products used in the fields of materials, daily chemicals, construction, textile, environmental protection and medical care, etc., enabling customers with efficient and stable enzyme catalyst products for industrial applications.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Website
- bio-synthera.com/
- Ownership
- Privately Held (backing)
Synthetic Era doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synthetic Era shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synthetic Era in its N-PORT filings yet. We sweep new filings monthly.